PBS Changes from 1 February 2026

Information relating to the new and amended Pharmaceutical Benefits Scheme (PBS) listings implemented on 1 February 2026 is now available.

USANZ Members may be particularly interested in items related to:

• Castration resistant metastatic carcinoma of the prostate

  Abiraterone & prednisolone (abiraterone acetate 500 mg tablet [56] & prednisolone 5 mg tablet [56], 112) (ANDRIGA-10®) is now listed on the PBS for the treatment of castration resistant metastatic carcinoma of the prostate. Authority applications for treatment can be made using the Online PBS Authorities system or by telephone

Download the PDF: PBS Listings 1 February 2026

This information relates to the administration of these listings by Services Australia. For further information, please download the Frequently Asked Questions. For information on broader PBS changes, please visit the PBS website. Relevant information and authority application forms have been updated and can be accessed through the Services Australia website.